Insider trading disclosure of September, 11 2017 received by Ognian Donev
Polski
Sopharma AD notifies that on 8 September 2017 Sopharma AD acquired 111 066 shares from the capital of Unipharm AD as a result of filed requests under the provisions of art. 177b from the LOPS.